The Luminex technology is an advanced multiplexing technique, especially suited for simultaneous detection of multiple cytokines and biomarkers. For the pre-clinical evaluation of tumor immunotherapies, our Luminex cytokine detection platform offers researchers precise and multiplexed data on cytokines and other immune response-related proteins.
Platform Features:
• Based on Luminex Technology: Utilizing color-coded microspheres and flow cytometry techniques, ensuring high sensitivity and specificity.
• Multiplex Detection: Capable of simultaneously detecting multiple cytokines, enhancing experimental efficiency and data richness.
• Minimal Sample Volume: Only 25μL of serum is required for concurrent experimental detection, reducing sample preparation costs.
• Broad Application: Particularly suitable for cytokine release assays, providing key data for drug screening and assessment.
Applications in Tumor and Pre-clinical Drug Evaluation for Tumor Immunotherapy:
• Multiplex Quantitative Analysis of Cytokines: Accurately measures levels of multiple cytokines, offering comprehensive data support for evaluating the effectiveness of immunotherapies.
• Cytokine Release Assays: Provides an experimental basis for drug screening and assessment, supporting the development of immunotherapies.
Why Choose Our Luminex Cytokine Detection Platform:
• Technological Leadership: Our platform is based on the cutting-edge Luminex technology, ensuring the accuracy and reliability of detection results.
• One-stop Service: From sample processing to data analysis, we provide comprehensive support for your needs.
• Experienced Team: Our team boasts extensive detection experience, providing robust technical support for your research.
Should you have any questions or require further information, please feel free to contact us.

Changes in peripheral blood cytokines after T-cell reconstitution 
• Safety detection of immunotherapy and cell therapy 
• Immune cell function detection